Commonly, the high expression of CDK1 is associated with over-proliferation and can be a prognostic factor in many cancers, including epithelial ovarian cancer [22], hepatocellular carcinoma [23], non-Hodgkin's lymphomas [24] and prostate cancer [25]. This evidence concerns the gene CDK1 and non-Hodgkin lymphoma.